Das et al. measured ERCC1 expression by immunohistochemical (IHC) analysis of CTCs from 17 patients with advanced NSCLC treated with platinum-based chemotherapy and found similar results: low ERCC1 expression on CTCs correlated with longer PFS [110]. Here, ERCC1 is linked to non-small cell lung carcinoma.